DRUG SAFETY 润色咨询

DRUG SAFETY

出版年份:1990 年文章数:1628 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:8.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=6f8b2051, cover=https://img.medsci.cn/images/journal/cover/2021/bpi_202109271314532220.jpg, fullname=DRUG SAFETY, abbr=DRUG SAFETY, pyear=1990, frequence=Monthly, articleNumbers=1628, citedSelf2015=8.3, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均24月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0114-5916, greenSci=https://www.greensci.net/search?kw=0114-5916, scijournal=https://www.scijournal.org/impact-factor-of-DRUG-SAFETY.shtml, medsciHotlightString=null, medsciHotlightRealtime=3.481, medsciHotlight=3.283, medsciHotlight5year=3.80924, citescore=6.7, hIndex=124, impactFactor=4.2, orgnization=Adis International Ltd, orgnizationUrl=http://www.adisonline.info/, country=United Kingdom, countryCn=英国, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Clinical Medicine|BIOSIS Previews|BIOSIS Reviews Reports And Meetings, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://link.springer.com/journal/40264, websiteHits=6898, guideForAuthor=null, guideForAuthorHits=2, submitWebsite=https://www.springer.com/journal/40264/submission, submitWebsiteHits=2047, content=Drug Safety is the only international review journal covering the disciplines of pharmacovigilance, pharmacoepidemiology and benefit-risk assessment. Drug Safety's structured programme of peer reviewed commissioned articles ensures comprehensive coverage of all topics. High quality original research focusing on the clinical implications of drug treatment safety issues is also published. Drug Safety specialises in definitive reviews on the epidemiology, clinical features, prevention and management of adverse effects of individual drugs or drug classes. Benefit-risk assessments provide you with an in-depth review of adverse effect and efficacy data for a drug in a specific disease. Drug Safety also features reviews covering drug use in particular 'at-risk' patient groups, and concept reviews of current thinking in pharmacovigilance, risk minimisation and medication error prevention. Articles focus on the practical aspects of ensuring the safest possible use of drugs, including analysis and interpretation of adverse effects, post-marketing surveillance and pharmacoepidemiology., totalCites=6838, brief=DRUG SAFETY杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=毒理学" >毒理学</a></strong>”子行业的优秀级杂志, articleType=本刊接收类型不明, medsciHeat=黑红, medsciComment=DRUG SAFETY在该细分领域可能是一流杂志,可能是创刊时间短或不是热门学科,整体来说,国内学者关注度仍然不够。对于投稿而言,建议多向"&abbr&"投稿,当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=6f8b2051'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=3.34), GetImpactFactorCiteScoreListResponse(year=2017, citescore=3.35), GetImpactFactorCiteScoreListResponse(year=2018, citescore=3.47), GetImpactFactorCiteScoreListResponse(year=2019, citescore=6.4), GetImpactFactorCiteScoreListResponse(year=2020, citescore=6.7)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=3.851), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=3.075), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=3.794), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=4.196), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=3.481)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Pharmacology (medical) , rank=38/232), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Toxicology , rank=19/114), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=65/300)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY, rank=Q2), GetImpactFactorCiteScoreGradeResponse(smallClass=PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH, rank=Q1), GetImpactFactorCiteScoreGradeResponse(smallClass=TOXICOLOGY, rank=Q2)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0114-5916[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=DRUG SAFETY[ta], article_number=485, article_number_cn=6, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
DRUG SAFETY/DRUG SAFETY
ISSN
0114-5916
影响指数话题
预警等级
MedSci期刊指数
3.481 (MedSci实时期刊指数) | 3.80924 (5年期刊指数)
CiteScore值
6.7
h-index
124
h5-median
暂无数据
出版社/管理机构
杂志由 Adis International Ltd 出版或管理
出版国家/地区
United Kingdom 英国
出版周期
Monthly
出版年份
1990
是否OA
被收录情况
Science Citation Index|Science Citation Index Expanded|Current Contents - Clinical Medicine|BIOSIS Previews|BIOSIS Reviews Reports And Meetings
JCR分区
PHARMACOLOGY & PHARMACY Q2
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Q1
TOXICOLOGY Q2
中科院分区
大类:医学 2区
小类:医学 2 区